ArticleThe Eurasian journal of medicine2025
A New Classification of Dermatochalasis, the Effect of This Classification and Blepharoplasty Surgery on the Visual Field.
Article in The Eurasian journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The aim is to create a new classification according to the contact and effect of dermatochalasis on the eyelashes and to examine the effect of blepharoplasty surgery on the visual field (VF) in these stages. Methods: Demographic characteristics of cases that were staged as dermatochalasis (group 1) (stage 1), (group 2) (stage 2), and (group 3) (stage 3) between February 2025 and April 2025 were examined, and changes in the VF before and after blepharoplasty were evaluated. Stage 1 was accepted as dermatochalasis only; stage 2 as dermatochalasis with eyelash contact but no eyelash inversion; and stage 3 as dermatochalasis creating inversion in the eyelashes. The Humphrey 30-2 test was applied in the VF. Mean deviation (MD), pattern standard deviation (PSD), visual field index (VFI), and upper half VF sensitivity were evaluated. Those with refractive error and additional eye diseases were not included in the study. Results: A total of 60 cases were examined, 20 in each group. The mean age of the cases was 42.7 ± 14.9 (28-75). Forty of the cases were female and 20 were male. The mean age was higher in group 3, and there was a statistically significant difference (P < 0.05). The changes in the VF in group 1 and group 2 were not statistically significant preoperatively and in the first month postoperatively (P > 0.05). In group 3, MD was -2.88 ± 1.20 (-3.63-2.10) dB, VFI was 97.45 ± 1.61 (89-92) dB, upper half VF sensitivity was 22.21 ± 1.54 (17-18.40) dB, and PSD was 2.19 ± 0.87 (1.2-2.02) dB at postoperative first month. The changes in group 3 were statistically significant preoperatively and in the first month postoperatively (P < 0.05). Conclusion: Dermatochalasis staging can predict the effect of dermatochalasis on the VF. This new dermatochalasis classification can be used in cases of equipment shortage. Visual field defects due to dermatochalasis can be corrected with blepharoplasty surgery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.